Bioelectronics

Bioelectronics is the branch of biomedical engineering that puts electrical, electrochemical, and electronic devices into intimate contact with living systems—to sense what the body is doing, to stimulate it into doing something else, or to couple biological molecules directly to circuits.

11 frameworks, from 1780 to today · Biomedical Engineering · Engineering

still a working view ended · each leads to its entry below

Overview

Bioelectronics is the branch of biomedical engineering that puts electrical, electrochemical, and electronic devices into intimate contact with living systems—to sense what the body is doing, to stimulate it into doing something else, or to couple biological molecules directly to circuits. Its practitioners build pacemakers and cochlear implants, electrode arrays that listen to single neurons, wearable patches that read a heartbeat through the skin, and, more recently, flexible films that wrap around a beating heart and molecular junctions in which a protein or a DNA strand is itself a component of a circuit. What is at stake is a two-way conversation between electronics and biology: the body's signals are ionic and wet, carried by ions moving through membranes and fluids, while circuits are electronic and dry, carried by electrons in wires and semiconductors. Nearly every advance in the field is, at bottom, a new answer to the problem of translating between these two languages without damaging the tissue that speaks one of them.

Galvanism and the Electrical Body

The field begins with a dispute about whether animal electricity was real. In the 1780s Luigi Galvani, an anatomist at Bologna, found that a frog's leg muscle twitched when touched by a metal scalpel while a nearby electrical machine was sparking. He pursued the phenomenon and concluded that the muscle itself contained a special "animal electricity."1 Alessandro Volta, professor at Pavia, disagreed: he argued the twitching came from the contact of two different metals through the moist tissue, and in 1800 he built the voltaic pile—the first battery—to prove that electricity could be generated by metals alone. Both were partly right. Volta's pile launched the electrical age, while Galvani's observation that living tissue responds to electrical current became the founding fact of electrophysiology. The word "galvanic" survives in the field for stimulation by direct current.

The next step was to show that the body generates its own electricity. In 1842 Carlo Matteucci, working in Italy, demonstrated that a current flows between the cut and intact surfaces of a frog muscle—a "demarcation current"—establishing that living tissue is a source of electricity, not merely a responder to it. In 1849 Emil du Bois-Reymond in Berlin, using a sensitive galvanometer, recorded the "action current" that accompanies a nerve impulse and proposed that nerves and muscles are excited by electrical changes at their surfaces. The idea that the nerve impulse is an electrical event was now on firm experimental ground, though the ionic mechanism behind it would not be explained until the twentieth century.

Recording the Body's Signals

Recording those tiny currents required instruments far more sensitive than a galvanometer. The capillary electrometer, and then in 1901 the string galvanometer of Willem Einthoven in Leiden, made it possible to record the heart's electrical activity through the skin. Einthoven's electrocardiogram (ECG)—a plot of the heart's electrical signal picked up by electrodes on the limbs—was a genuine instrument of clinical medicine, and he received the Nobel Prize in 1924 for it. The principle he established, that electrodes on the body surface can capture the summed electrical activity of an organ, underlies essentially all later electrophysiological recording.

At the cellular scale, the key advance was the glass microelectrode: a fine glass pipette drawn to a tip a fraction of a micrometre across, filled with salt solution, and pushed through a cell membrane to record the voltage across it. In the 1940s and 1950s Alan Hodgkin and Andrew Huxley at Cambridge used such electrodes on the giant nerve fibre of the squid to record the action potential directly and to work out its ionic basis, publishing their quantitative model in 1952. The microelectrode made the single cell the unit of electrophysiology, and it set the target that later bioelectronics would pursue: recording from many cells at once, in living tissue, over long periods.

Pacing the Heart

The first durable therapeutic bioelectronic device was the implantable cardiac pacemaker. The heart's own rhythm can fail—the natural pacemaker slows or conduction between chambers breaks down—and an artificial electrical stimulus delivered at the right moment can restore a coordinated beat. External pacemakers existed by the 1950s, but they were bulky and tethered the patient to equipment. In 1958 Rune Elmqvist, an engineer, and Åke Senning, a surgeon, at the Karolinska Institute in Stockholm implanted a pacemaker powered by rechargeable nickel-cadmium batteries into a patient; the device was encapsulated in epoxy resin and lasted only a short time before failing, but it demonstrated the principle. The critical enabling change came with the mercury-zinc cell and then, in 1971, with the lithium-iodine battery developed by Wilson Greatbatch, which was small, sealed, and lasted years. Pacemakers became routine, and the field learned a lesson it would apply repeatedly: a bioelectronic implant is only as good as its packaging and its power source, because the body is a corrosive, warm, wet environment that destroys unprotected electronics.

Biosensors and the Transduction Problem

A biosensor is a device that converts a biological recognition event—an enzyme meeting its substrate, an antibody binding its antigen—into a measurable electrical signal. The founding demonstration came in 1962, when Leland Clark and Champ Lyons built an enzyme electrode: glucose oxidase immobilized at an oxygen electrode, so that the enzyme's consumption of oxygen, proportional to glucose concentration, could be read electrically. This "Clark electrode" approach became the basis of the glucose biosensor, and the amperometric enzyme electrode—measuring current produced by an electrochemical reaction—became the dominant transduction scheme. The problem it solved was specificity: earlier chemical sensors could measure a substance but not distinguish it from similar molecules, whereas coupling a biological recognition element to a transducer gave the sensor the selectivity of biology. The commercial glucose meter, which let a diabetic read blood sugar from a drop of blood, was the first mass-market bioelectronic product, and it established the pattern of a disposable sensing element read by a reusable instrument.

Coupling Cells to Transistors

The next ambition was to record living cells not with electrodes pushed into them but with electronics they could sit on. The field-effect transistor, in which a voltage at a gate controls current through a channel, offered a way: a cell resting on the gate could influence the current2. In the 1970s and 1980s, work by Piet Bergveld in the Netherlands on ion-sensitive field-effect transistors (ISFETs)—transistors whose gate responds to ions in solution—showed that semiconductor devices could sense chemical and electrical activity in fluid3. The decisive step came in 1991, when Peter Fromherz and colleagues at the Max Planck Institute in Martinsried reported coupling a single neuron to a field-effect transistor, showing that the cell's electrical activity could be detected by the transistor beneath it without penetrating the membrane. This "cell–transistor coupling" opened the possibility of arrays of transistors, each listening to a cell, as a non-invasive alternative to microelectrodes.

Microelectrode Arrays and Neural Stimulation

Recording from many neurons at once required arrays of electrodes. The microelectrode array—a grid of small conducting sites on a substrate, each connected to recording electronics—was developed for in vitro use in the 1970s and 1980s, notably by Jerome Pine and by Guenter Gross, who showed that networks of cultured neurons could be recorded and stimulated across many sites simultaneously. For use in living brain, the Utah electrode array, a silicon array of penetrating needles developed at the University of Utah in the 1990s, and the Michigan-style silicon probes gave researchers access to many neurons in vivo. These arrays made possible the long-term recording that brain–computer interfaces depend on.

Stimulation advanced in parallel. The cochlear implant, which stimulates the auditory nerve with an array of electrodes to restore hearing, was pioneered by several groups from the 1960s onward; the work of Graeme Clark in Melbourne and of Claude-Henri Chouard in Paris in the 1970s led to multichannel devices that by the 1980s were restoring speech perception to profoundly deaf patients. Deep brain stimulation—implanting electrodes in deep brain structures and driving them with a pulse generator—was developed in the 1980s and 1990s, notably by Alim-Louis Benabid and colleagues in Grenoble, for tremor in Parkinson's disease, and became an established therapy. Each of these devices confronted the same engineering problem: delivering charge to tissue without corroding the electrode or damaging the neurons, which pushed the field toward careful electrode materials and charge-balanced stimulation waveforms.

Molecular Bioelectronics

A different strand of the field asks whether biological molecules themselves can serve as electronic components4. In 1974, Arieh Aviram and Mark Ratner, then at IBM, published a theoretical paper proposing that a single organic molecule between two electrodes could act as a rectifier—a one-way valve for electrons. This founded the idea of molecular electronics. The biological version followed: proteins and DNA were examined as conductors and switches. In the 1990s and 2000s, experiments on electron transfer through DNA and through redox proteins, and the demonstration that a protein can be wired between electrodes and retain its function, established molecular bioelectronics as a research program. Its promise is extreme miniaturization and direct integration of biological recognition with electronic readout; its difficulty is that molecules are fragile and their contacts with electrodes are hard to control reproducibly.

Flexible and Stretchable Electronics

The body is soft, curved, and moving; conventional rigid silicon and metal packages are none of these. A rigid implant on a beating heart or a folding brain surface causes inflammation and eventually fails mechanically. The response, developed from the 2000s onward, was to make bioelectronic devices mechanically matched to tissue: thin films of silicon and metal on flexible polymer substrates, and then stretchable designs in which conducting traces are patterned into wavy or serpentine shapes that unfold as the tissue moves. John Rogers and colleagues demonstrated stretchable, conformal electronic sheets that could wrap a beating heart and record its electrical activity; similar approaches produced electrode arrays that conform to the brain surface. The problem solved was the mechanical mismatch at the tissue interface, and the result was devices that could stay in place and function for long periods without the body rejecting them.

Optogenetics and Closed-Loop Control

Two developments in the 2000s changed what bioelectronic devices could do. The first was optogenetics: the discovery, reported in 2005 by Karl Deisseroth and colleagues at Stanford and by the laboratory of Gero Miesenböck, that light-sensitive proteins from algae and bacteria could be expressed in neurons so that light could switch those neurons on or off. This gave researchers a way to control specific populations of cells with light rather than with electrodes, and it drove the development of implantable light-delivery devices—a bioelectronic interface using photons instead of charge.

The second was closed-loop neuromodulation: devices that sense the brain's activity and adjust stimulation in response, rather than delivering a fixed pulse. The responsive neurostimulator, approved for epilepsy in the 2010s, detects the onset of a seizure and delivers stimulation to abort it. Closed-loop control turns a stimulator into a feedback system, and it depends on the recording and stimulation technologies built earlier in the field's history.

The Present

Today bioelectronics works across several fronts that descend directly from this history. Implantable stimulation devices—pacemakers, cochlear implants, deep brain stimulators, spinal cord stimulators—are mature clinical products, and the engineering effort has shifted toward smaller, leadless, and closed-loop designs. Flexible and stretchable electrode arrays are moving from laboratory demonstrations toward chronic implants. Microelectrode arrays and cell–transistor interfaces support both neuroscience and the development of brain–computer interfaces. Biosensors have expanded from glucose to a wide range of analytes and toward wearable and continuous monitoring. Molecular bioelectronics remains largely exploratory, seeking reliable ways to wire single molecules and proteins into circuits. The open questions are the old ones in new form: how to keep an electronic device stable and functional inside living tissue for years, how to record and stimulate many cells without damaging them, and how to close the loop between sensing and action tightly enough to treat disease as it happens rather than on a fixed schedule.

References

  1. Galvanic cell (History), Wikipedia
  2. Field-effect transistor, Wikipedia
  3. ISFET (introduction, History), Wikipedia
  4. Molecular electronics, Wikipedia

The frameworks of Bioelectronics

Each framework is a way of working the field has used: when it held, and the question it answers.

  1. 1780-1900

    Electrophysiology

    How do living tissues generate and respond to electricity?

    Fly to its tower in Nousfarer

  2. 1901-Present

    Electrophysiological recording

    How can we record the electrical activity of the body?

    Fly to its tower in Nousfarer

  3. 1958-Present

    Implantable cardiac pacing

    How can we restore a failing heart rhythm with electrical stimulation?

    Fly to its tower in Nousfarer

  4. 1958-Present

    Implantable neurostimulation

    How can we treat neurological disorders with implanted electrical stimulation?

    Fly to its tower in Nousfarer

  5. 1962-Present

    Biosensor

    How can we detect specific biological molecules electrically?

    Fly to its tower in Nousfarer

  6. 1970-Present

    Cell–transistor coupling

    How can living cells be coupled to transistors without penetration?

    Fly to its tower in Nousfarer

  7. 1970-Present

    Microelectrode array

    How can we record from many neurons simultaneously?

    Fly to its tower in Nousfarer

  8. 1974-Present

    Molecular bioelectronics

    How can biological molecules act as electronic components?

    Fly to its tower in Nousfarer

  9. 2000-Present

    Flexible and stretchable bioelectronics

    How can electronics conform to soft living tissue?

    Fly to its tower in Nousfarer

  10. 2005-Present

    Closed-loop neuromodulation

    How can we adjust stimulation in real time based on neural feedback?

    Fly to its tower in Nousfarer

  11. 2005-Present

    Optogenetics

    How can we control specific neurons with light?

    Fly to its tower in Nousfarer

How the ideas connect

Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.

ElectrophysiologyElectrophysiological recordingImplantable cardiac pacingImplantable neurostimulationBiosensorCell–transistor couplingMicroelectrode arrayMolecular bioelectronicsFlexible and stretchable bioelectroni…Closed-loop neuromodulationOptogenetics

Beyond the field

Where Bioelectronics's ideas came from in other fields, and what they led to there: the strongest 12 of 75 links.

A city in Nousfarer: a red-carpeted stair climbing terraces to a crowned tower on an acropolis, more towers round it, forest and snowy mountains beyond.
A city in Nousfarer, the game played in the browser.

Bioelectronics is a planet in Nousfarer

Its city has a tower for each of these 11 frameworks. Land, walk in, and climb one concept at a time.

Land on Bioelectronics

Related fields

Fields its ideas are linked to

More in Biomedical Engineering

See where Bioelectronics sits on the Map of Human Knowledge